Welcome to
On Feet Nation
farhan Online
Posted by John Snow on February 24, 2025 at 3:10pm 0 Comments 0 Likes
Posted by Micheal Jorden on February 24, 2025 at 2:41pm 0 Comments 0 Likes
Posted by Jack Miller on February 24, 2025 at 12:25pm 0 Comments 0 Likes
Posted by Jerold Galarza on February 24, 2025 at 12:11pm 0 Comments 0 Likes
Summary - A new market study, titled “Global Influenza Vaccine Market Report 2022” has been featured on WiseGuy Reports.
About Influenza Vaccine
Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes moderate to severe illness, while the infection due to influenza B virus results in milder disease and affects pediatrics primarily. Human illness due to influenza C is rare. Influenza C illness might be due to subclinical cases. Hence, it does not cause epidemic diseases. Influenza has emerged as a severe health concern globally. The market encompasses both live attenuated as well as recombinant influenza vaccines for the prevention of influenza. The major factors that lead to the market growth include the need for annual vaccination and government initiatives to improve awareness about vaccination.
ALSO READ : https://www.medgadget.com/2020/10/influenza-vaccine-market-global-i...
Technavio’s analysts forecast the global influenza vaccine market to grow at a CAGR of 7.23% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global influenza vaccine market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of influenza vaccine.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Influenza Vaccine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AstraZeneca
• CSL
• GlaxoSmithKline
• Sanofi
Other prominent vendors
• Altimmune
• BionVax
• FluGen
• FOLIA BIOTECH
• Genentech
• Green Cross
• Medicago
• Moderna Therapeutics
• Novavax
• Shijiazhuang Yiling Pharmaceutical
• SK Chemicals
• UNM Pharma
• Vaccitech
• Vaxart
• Vaxine Pty
• Visterra.
Market driver
• Rising awareness about influenza vaccination
• For a full, detailed list, view our report
Market trend
• Development of strong pipeline
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/2771341-global-influenza-vac...
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
sales@WiseGuy Reports.com
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)
© 2025 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation